Lipid Profile, Nonfasting, Pediatric
Use
Assessment of cardiovascular health and risk stratification in pediatric, adolescent, and young adult populations.
Special Instructions
Not provided.
Limitations
Patients with obstructive liver disease may develop lipoprotein abnormalities. In the absence of a clinical or historic marker, identification of children with lipid disorders that predispose them to accelerated atherosclerosis requires universal lipid assessment.
Methodology
Automated Analyzer (Clinical Chemistry)
Biomarkers
Cholesterol, Total
AnalyteHDL Cholesterol
AnalyteNon-HDL Cholesterol
Analyte
LOINC Codes
- 2085-9 - HDLc SerPl-mCnc
- 2093-3 - Cholest SerPl-mCnc
- 43396-1 - NonHDLc SerPl-mCnc
- 2093-3 - Cholest SerPl-mCnc
- 2085-9 - HDLc SerPl-mCnc
- 43396-1 - NonHDLc SerPl-mCnc
- 77202-0 - Laboratory comment Report
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
0.7 mL
Container
Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube. Do not use oxalate, EDTA, or citrate plasma.
Collection Instructions
Separate serum or plasma or from cells within 45 minutes of collection.
Patient Preparation
Nonfasting
Storage Instructions
Maintain specimen at room temperature. Stable at room temperature, refrigerated or frozen for seven days.
Causes for Rejection
Hemolysis
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 7 days |
| Frozen | 7 days |
Other tests from different labs that may be relevant